Literature DB >> 18304229

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation associated with a congenital bilateral absence of vas deferens.

Hideo Sakamoto1, Takatoshi Yajima, Kohta Suzuki, Yoshio Ogawa.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations associated with cystic fibrosis have been reported to be rare in Japanese patients with congenital bilateral absence of vas deferens (CBAVD). A 28-year-old Japanese male was referred for infertility. Vas deferens and epididymis were not palpable bilaterally. Semen analyses showed azoospermia with volumes below 2.0 ml. Serum follicle-stimulating hormone value was slightly elevated. Seminal fructose concentration was also very low. Scrotal ultrasonography showed absence of the bodies and tails of the right and left epididymides. Imaging studies showed cystic dysplasia of the right seminal vesicle and agenesis of the left seminal vesicle. A CFTR gene mutation of I556V was found. Recent studies show that prevalence of CFTR gene mutation in Japanese CBAVD patients may be approximately equal to that of the Caucasian population. Genetic counselling may be recommended for any couple attempting assisted reproduction technology when the man has CBAVD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304229     DOI: 10.1111/j.1442-2042.2007.01974.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk.

Authors:  Regine M Lim; Ari J Silver; Maxwell J Silver; Carlos Borroto; Brett Spurrier; Tanya C Petrossian; Jessica L Larson; Lee M Silver
Journal:  Genet Med       Date:  2015-04-16       Impact factor: 8.822

2.  Ultrasonography in Diagnosis of Congenital Absence of the Vas Deferens.

Authors:  Liang Li; Chaozhao Liang
Journal:  Med Sci Monit       Date:  2016-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.